These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 30982889)

  • 21. CRISPR/Cas9-Mediated miR-29b Editing as a Treatment of Different Types of Muscle Atrophy in Mice.
    Li J; Wang L; Hua X; Tang H; Chen R; Yang T; Das S; Xiao J
    Mol Ther; 2020 May; 28(5):1359-1372. PubMed ID: 32222157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthetic switch to minimize CRISPR off-target effects by self-restricting Cas9 transcription and translation.
    Shen CC; Hsu MN; Chang CW; Lin MW; Hwu JR; Tu Y; Hu YC
    Nucleic Acids Res; 2019 Feb; 47(3):e13. PubMed ID: 30462300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optical Control of a CRISPR/Cas9 System for Gene Editing by Using Photolabile crRNA.
    Zhang Y; Ling X; Su X; Zhang S; Wang J; Zhang P; Feng W; Zhu YY; Liu T; Tang X
    Angew Chem Int Ed Engl; 2020 Nov; 59(47):20895-20899. PubMed ID: 33448579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A microRNA-inducible CRISPR-Cas9 platform serves as a microRNA sensor and cell-type-specific genome regulation tool.
    Wang XW; Hu LF; Hao J; Liao LQ; Chiu YT; Shi M; Wang Y
    Nat Cell Biol; 2019 Apr; 21(4):522-530. PubMed ID: 30804503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent Advances in CRISPR/Cas9-Mediated Genome Editing in
    Muramoto T; Iriki H; Watanabe J; Kawata T
    Cells; 2019 Jan; 8(1):. PubMed ID: 30642074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving CRISPR-Cas9 Genome Editing Efficiency by Fusion with Chromatin-Modulating Peptides.
    Ding X; Seebeck T; Feng Y; Jiang Y; Davis GD; Chen F
    CRISPR J; 2019 Feb; 2():51-63. PubMed ID: 31021236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-efficiency genome editing using a dmc1 promoter-controlled CRISPR/Cas9 system in maize.
    Feng C; Su H; Bai H; Wang R; Liu Y; Guo X; Liu C; Zhang J; Yuan J; Birchler JA; Han F
    Plant Biotechnol J; 2018 Nov; 16(11):1848-1857. PubMed ID: 29569825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the AcrIIC1 anti‒CRISPR protein for Cas9‒based genome engineering in E. coli.
    Trasanidou D; Potocnik A; Barendse P; Mohanraju P; Bouzetos E; Karpouzis E; Desmet A; van Kranenburg R; van der Oost J; Staals RHJ; Mougiakos I
    Commun Biol; 2023 Oct; 6(1):1042. PubMed ID: 37833505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacterial CRISPR/Cas DNA endonucleases: A revolutionary technology that could dramatically impact viral research and treatment.
    Kennedy EM; Cullen BR
    Virology; 2015 May; 479-480():213-20. PubMed ID: 25759096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Near-infrared optogenetic engineering of photothermal nanoCRISPR for programmable genome editing.
    Chen X; Chen Y; Xin H; Wan T; Ping Y
    Proc Natl Acad Sci U S A; 2020 Feb; 117(5):2395-2405. PubMed ID: 31941712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation of a novel HEK293 luciferase reporter cell line by CRISPR/Cas9-mediated site-specific integration in the genome to explore the transcriptional regulation of the PGRN gene.
    Li Y; Li S; Li Y; Xia H; Mao Q
    Bioengineered; 2019 Dec; 10(1):98-107. PubMed ID: 31023186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Profiling Genome-Wide Specificity of CRISPR-Cas9 Using Digenome-Seq.
    Kim D; Kim JS
    Methods Mol Biol; 2021; 2162():233-242. PubMed ID: 32926386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogold Labeling to Detect
    Ulloa-Navas MJ; García-Tárraga P; García-Verdugo JM; Herranz-Pérez V
    CRISPR J; 2019 Dec; 2(6):395-405. PubMed ID: 31860352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induced mutation and epigenetics modification in plants for crop improvement by targeting CRISPR/Cas9 technology.
    Khan MHU; Khan SU; Muhammad A; Hu L; Yang Y; Fan C
    J Cell Physiol; 2018 Jun; 233(6):4578-4594. PubMed ID: 29194606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potent CRISPR-Cas9 inhibitors from
    Watters KE; Shivram H; Fellmann C; Lew RJ; McMahon B; Doudna JA
    Proc Natl Acad Sci U S A; 2020 Mar; 117(12):6531-6539. PubMed ID: 32156733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methods for In Vivo CRISPR/Cas Editing of the Adult Murine Retina.
    Hung SS; Li F; Wang JH; King AE; Bui BV; Liu GS; Hewitt AW
    Methods Mol Biol; 2018; 1715():113-133. PubMed ID: 29188510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-focused CRISPR-Cas9 library screen reveals fitness-associated miRNAs.
    Kurata JS; Lin RJ
    RNA; 2018 Jul; 24(7):966-981. PubMed ID: 29720387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of Cas9 level for efficient CRISPR-Cas9-mediated chromosomal and plasmid gene deletion in Bacillus thuringiensis.
    Soonsanga S; Luxananil P; Promdonkoy B
    Biotechnol Lett; 2020 Apr; 42(4):625-632. PubMed ID: 31960185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic editing by CRISPR/dCas9 in
    Xiao B; Yin S; Hu Y; Sun M; Wei J; Huang Z; Wen Y; Dai X; Chen H; Mu J; Cui L; Jiang L
    Proc Natl Acad Sci U S A; 2019 Jan; 116(1):255-260. PubMed ID: 30584102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system.
    Lyu C; Shen J; Wang R; Gu H; Zhang J; Xue F; Liu X; Liu W; Fu R; Zhang L; Li H; Zhang X; Cheng T; Yang R; Zhang L
    Stem Cell Res Ther; 2018 Apr; 9(1):92. PubMed ID: 29625575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.